Asterias Biotherapeutics, Inc.

Transdermal delivery of medicines is not a new idea – a transdermal patch designed for the delivery of scopolamine, for motion sickness, and post-operative nausea and vomiting, was first approved for

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . BI, Epizyme See Helicase, HA

Novo Nordisk AS has increased the number of planned lay-offs to 1,300 world-wide from an initially announced 400 to reallocate resources needed for drug discovery exploration in new disease areas, in

A recent string of breakthroughs in stem cell research, coupled with the need to more fully integrate AI and computer sciences in drug development, lay behind Novo Nordisk AS 's decision to restructu